Lantheus Holdings (LNTH) EBT (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly EBT of $156.4 million for Q1 2026, up 62.03% year-over-year from $96.5 million in Q1 2025, and up 103.55% quarter-over-quarter from $76.8 million in Q4 2025.
Lantheus Holdings (LNTH) EBT (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported EBT for 13 consecutive years, with $156.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 62.03% year-over-year to $156.4 million; the TTM figure through Mar 2026 stood at $380.1 million (up 616.07% YoY), while the FY2025 annual figure was $320.3 million, up 29609.18% from the prior year.
- EBT climbed to $156.4 million in Q1 2026 per LNTH's latest filing, from $76.8 million in the prior quarter.
- Across five years, EBT topped out at $176.1 million in Q3 2024 and bottomed at -$430.7 million in Q4 2024.
- Historically, EBT has averaged $53.8 million across 5 years, with a median of $84.4 million in 2024.
- On a YoY basis, EBT climbed as much as 1642.4% in 2024 and fell as far as 411.18% in 2024.
- Lantheus Holdings' EBT stood at -$176.2 million in 2022, then surged by 178.53% to $138.4 million in 2023, then sank by 411.18% to -$430.7 million in 2024, then jumped by 117.84% to $76.8 million in 2025, then surged by 103.55% to $156.4 million in 2026.
- Business Quant data shows LNTH's EBT at $156.4 million in Q1 2026, $76.8 million in Q4 2025, and $42.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 93.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.83 Mn |
| Mar 31, 2026 | 156.41 Mn |
| Dec 31, 2025 | 76.84 Mn |
| Sep 30, 2025 | 42.38 Mn |
| Jun 30, 2025 | 104.52 Mn |
| Mar 31, 2025 | 96.53 Mn |
| Dec 31, 2024 | -430.68 Mn |
| Sep 30, 2024 | 176.12 Mn |
| Jun 30, 2024 | 84.37 Mn |
| Mar 31, 2024 | 171.27 Mn |
| Dec 31, 2023 | 138.40 Mn |
| Sep 30, 2023 | 159.96 Mn |
| Jun 30, 2023 | 123.69 Mn |
| Mar 31, 2023 | -11.10 Mn |
| Dec 31, 2022 | -176.24 Mn |
| Sep 30, 2022 | 83.02 Mn |
| Jun 30, 2022 | 62.05 Mn |
| Mar 31, 2022 | 57.90 Mn |
| Dec 31, 2021 | -41.01 Mn |
| Sep 30, 2021 | -19.84 Mn |